Psychiatry – Page 2

Characterization of Patient-Reported Sleep and Mood Symptoms in Chronic Mild Traumatic Brain Injury: A Comprehensive Review

By MedXY 08/16/2026

This review synthesizes evidence highlighting the high prevalence and interrelation of sleep disturbances, mood symptoms, and cognitive impairments in chronic mild traumatic brain injury (mTBI), emphasizing the need for integrated assessment and management.

news Psychiatry Public Health

Structure of the Genetic Risks for Psychiatric Disorders in Swedish Population-Based Registries

By MedXY 08/15/2026

This study investigates the genetic risk structure of 18 psychiatric and substance use disorders using high-quality Swedish registries, identifying six distinct genetic factors and highlighting shared and unique genetic influences among disorders.

Critical Care news Psychiatry

Psychoactive Medication Prescribing After Critical Illness in American Adults Not Justified by a Documented Supporting Diagnosis

By MedXY 08/15/2026

Nearly half of psychoactive medications newly prescribed after ICU stays in American adults lack documented diagnostic justification, persisting for up to two years post-hospitalization.

Neurology news Psychiatry

Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium

By MedXY 08/12/2026

An international study reveals that childhood trauma’s association with bipolar disorder is partially mediated by brain morphology changes, particularly in hippocampal volume and frontal cortical thickness.

news Psychiatry Public Health

Optimizing Task-Shared Psychosocial Interventions for Depression and Anxiety: Key Components and Personalized Approaches

By MedXY 08/11/2026

A large-scale study identifies key active components of psychosocial interventions delivered by non-specialists, revealing social support, behavioral activation, and problem management as most effective for treating common mental disorders, while emphasizing personalized treatment based on individual characteristics.

news Psychiatry

Navigating Conflicting Clinical Trial Evidence: The FDA’s Approval Journey of Gepirone Extended Release for Major Depression

By MedXY 08/11/2026

This article critically examines the FDA's approval of gepirone ER for major depressive disorder despite multiple negative trials, highlighting regulatory flexibility, statistical and clinical considerations, and implications for transparency in drug labeling.

Diabetes & Endocrinology news Psychiatry

GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study

By MedXY 08/10/2026

This Swedish register-based study reveals that GLP-1 receptor agonists are associated with significantly reduced hospitalisations for alcohol and substance use disorders during treatment, with some lasting benefits after discontinuation of therapy for alcohol use disorder.

Neurology news Psychiatry

Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial

By MedXY 08/10/2026

This randomized trial compared connectivity-based versus scalp-based targeting of accelerated TMS in treatment-resistant depression, showing greater antidepressant effects with individualized connectivity-guided targeting.

Clinical Updates news Psychiatry Public Health

Characteristics of Higher-Education Students in England Who Died by Suspected Suicide: A National Retrospective Case Series Study

By MedXY 08/07/2026

This review synthesizes evidence on individual and institutional factors linked to suspected suicide among higher-education students in England, highlighting risk profiles, service contact patterns, and shortcomings in investigation practices, to inform targeted prevention strategies.

news Psychiatry

Time-Dependent Symptom Improvement in Schizophrenia: Insights from Six Antipsychotic Trials

By MedXY 08/05/2026

This analysis of six antipsychotic trials reveals distinct temporal patterns in the improvement of schizophrenia symptom domains, with hostility and excitement responding fastest and negative and cognitive symptoms improving more slowly, guiding clinicians on treatment expectations.

General Surgery news Psychiatry

Bridging the Mental Health Care Gap for Trauma Patients at Risk of PTSD: Insights from Social Workers

By MedXY 08/04/2026

This article examines the current gaps and strengths in mental health services for trauma surgery patients at risk of PTSD, highlighting underutilization of guidelines, barriers to care, and opportunities for improving psychosocial support.

Clinical Updates news OB/GYN & Women's Health Psychiatry

Antidepressant Continuation During Pregnancy and Its Impact on Postpartum Depression Risk Across Diverse Populations

By MedXY 08/04/2026

Continuing antidepressants in pregnancy lowers postpartum depression risk irrespective of race or ethnicity; prenatal depressive symptoms severity is critical for personalized treatment.

news Plastic Surgery Psychiatry

Impact of Preoperative Serotonergic Antidepressants on Post-Rhinoplasty Outcomes: A Propensity Score-Matched Study

By MedXY 07/30/2026

Preoperative use of serotonergic antidepressants is linked to increased short-term postoperative complications after rhinoplasty, including higher rates of bleeding, readmission, and opioid use, without affecting long-term revision rates.

Clinical Updates news Pediatrics Psychiatry

Adolescent Peer Influences on Mental Disorder Risk: Diagnoses and Genetic Predispositions in Population Cohorts

By MedXY 07/30/2026

Peer networks in adolescence, especially in upper secondary school, significantly influence the risk trajectory for mental disorders through peers' diagnosed conditions and genetic predispositions, with subtype-specific and cross-disorder effects.

Clinical Updates Neurology news Psychiatry

Mapping 2-Year Psychiatric and Neurologic Risks After Infections Across Body Systems and Age Groups: An Integrative Review

By MedXY 07/21/2026

This review synthesizes evidence on 2-year psychiatric and neurologic risks post infections across body systems and age groups, highlighting infection-specific risk profiles, age-dependent vulnerability, and mechanistic insights from recent cohort and prospective studies.

Neurology news Psychiatry

Familial Microvascular Traits and Neuropsychiatric Factors Reflected in Brain Perivascular Space Morphometry

By MedXY 07/20/2026

Brain perivascular space morphometry reveals familial microvascular architecture and neuropsychiatric influences, offering a novel imaging biomarker of cerebral microvascular health beyond traditional vascular risk factors.

news Psychiatry Radiology

Differential Brain Lithium Dynamics in Bipolar Disorder: Insights from 7Li MRI Comparing Once- vs Twice-Daily Dosing Regimens

By MedXY 07/17/2026

This study uses advanced 7Li MRI to reveal how brain lithium kinetics closely track serum levels in bipolar disorder patients under once- versus twice-daily lithium dosing, highlighting implications for dosing schedules and therapeutic monitoring.

news Psychiatry

LB-102 in Acute Schizophrenia: A Promising Benzamide Antipsychotic with Demonstrated Efficacy and Safety

By MedXY 07/17/2026

The phase 2 NOVA1 trial demonstrates that LB-102 significantly improves acute schizophrenia symptoms with a favorable safety profile, supporting its potential as a novel treatment option.

news Psychiatry Public Health

Evaluating the Economic Impact of Enhanced Primary Youth Mental Health Services: Insights from the ACCESS Open Minds Study

By MedXY 07/14/2026

A retrospective cohort study of ACCESS Open Minds in Canada demonstrates significant cost savings and improved service utilization in youth mental health care through enhanced, community-based services.

news Psychiatry

Comparative Effectiveness of Dialectical Behavior Therapy and Schema Therapy in Borderline Personality Disorder: Insights from the BOOTS Trial

By MedXY 07/14/2026

The BOOTS multicenter RCT found no significant difference in long-term effectiveness between dialectical behavior therapy (DBT) and schema therapy (ST) for borderline personality disorder (BPD), with both treatments yielding substantial clinical improvements.